Media

Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH

Vicore has carried out a directed share issue of 10,000,000 shares at a subscription price of SEK 20 per share, raising gross proceeds of SEK 200 million

Oncopeptides provides update on Pepaxto US marketing authorization

Vicore announces first patient enrolled in COMPANION; a digital therapeutic pivotal study for patients with pulmonary fibrosis

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

Priothera – Positive mocravimod Phase 1b clinical data published in Transplantation and Cellular Therapy

Oncopeptides’ Pepaxti has been granted marketing authorization in the UK

Spruce Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Updates

Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement